Cobalis Signs Agreement With Trendtrade to Market PreHistin in Australia

Cobalis Corp., a pharmaceutical company specializing in the development of anti-allergy medications, announced that the Company has signed a comprehensive marketing consulting agreement with Sydney, Australia-based Trendtrade International Pty. to be the Company's representative/partner for Australian marketing. Under this agreement, Cobalis has engaged the extensive services of Trendtrade to assist the Company with all aspects of preparing to bring its anti-allergy product PreHistin to market in Australia later in 2005.

Yahoo News (http://biz.yahoo.com/bw/050322/225286_1.html)